These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37264550)

  • 1. Physiological and pathophysiological roles of hepoxilins and their analogs.
    Helal SA; Isse FA; Gerges SH; El-Kadi AOS
    Drug Metab Rev; 2023 Aug; 55(3):254-266. PubMed ID: 37264550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepoxilins in cancer and inflammation--use of hepoxilin antagonists.
    Pace-Asciak CR
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):493-506. PubMed ID: 22005952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
    Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
    J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepoxilins and some analogues: a review of their biology.
    Pace-Asciak CR
    Br J Pharmacol; 2009 Oct; 158(4):972-81. PubMed ID: 19422397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, biochemistry and biology of hepoxilins: an update.
    Nigam S; Zafiriou MP; Deva R; Ciccoli R; Roux-Van der Merwe R
    FEBS J; 2007 Jul; 274(14):3503-3512. PubMed ID: 17608719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia.
    Gregus AM; Dumlao DS; Wei SC; Norris PC; Catella LC; Meyerstein FG; Buczynski MW; Steinauer JJ; Fitzsimmons BL; Yaksh TL; Dennis EA
    FASEB J; 2013 May; 27(5):1939-49. PubMed ID: 23382512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepoxilin analogs, potential new therapeutics in disease.
    Pace-Asciak CR; Li X; Qiao N; Reynaud D; Demin P; Abdelhaleem M
    Curr Pharm Des; 2006; 12(8):963-9. PubMed ID: 16533163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepoxilins modulate second messenger systems in the human neutrophil.
    Pace-Asciak CR; Nigam S
    Adv Exp Med Biol; 1991; 314():133-9. PubMed ID: 1818483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel platelet antiaggregating substances.
    Reynaud D; Sun A; Demin P; Pace-Asciak CR
    Biochem Biophys Res Commun; 2001 Jun; 284(3):580-2. PubMed ID: 11396939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of polyunsaturated fatty acids to bioactive hepoxilins and trioxilins by microbial enzymes.
    An JU; Song YS; Kim KR; Ko YJ; Yoon DY; Oh DK
    Nat Commun; 2018 Jan; 9(1):128. PubMed ID: 29317615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of the hepoxilins.
    Pace-Asciak CR
    Biochim Biophys Acta; 2015 Apr; 1851(4):383-96. PubMed ID: 25240838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of 14,15-hepoxilins of the A(3) and B(3) series through a 15-lipoxygenase and hydroperoxide isomerase present in garlic roots.
    Reynaud D; Ali M; Demin P; Pace-Asciak CR
    J Biol Chem; 1999 Oct; 274(40):28213-8. PubMed ID: 10497175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonate metabolism in blood cells and the vessel wall.
    Moncada S; Higgs EA
    Clin Haematol; 1986 May; 15(2):273-92. PubMed ID: 3015465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP.
    Reynaud D; Hinek A; Pace-Asciak CR
    FEBS Lett; 2002 Mar; 515(1-3):58-60. PubMed ID: 11943194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the cellular metabolism of the click chemistry probe 19-alkyne arachidonic acid.
    Robichaud PP; Poirier SJ; Boudreau LH; Doiron JA; Barnett DA; Boilard E; Surette ME
    J Lipid Res; 2016 Oct; 57(10):1821-1830. PubMed ID: 27538823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepoxilin analogs, PBT-3 and PBT-4, cause apoptosis of Gleevec-resistant K562 cells in vitro.
    Qiao N; Reynaud D; Abdelhaleem M; Pace-Asciak CR
    In Vivo; 2007; 21(2):267-71. PubMed ID: 17436575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid.
    Takenaga M; Hirai A; Terano T; Tamura Y; Kitagawa H; Yoshida S
    Thromb Res; 1986 Feb; 41(3):373-84. PubMed ID: 3010490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient induction of leukotriene synthesis in human neutrophils by lipoxygenase-deficient platelets.
    Kanaji K; Okuma M; Uchino H
    Blood; 1986 Apr; 67(4):903-8. PubMed ID: 3006834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepoxilin analog PBT-3 induces apoptosis in BCR-ABL-positive K562 leukemia cells.
    Qiao N; Lam J; Reynaud D; Abdelhaleem M; Pace-Asciak CR
    Anticancer Res; 2003; 23(5A):3617-22. PubMed ID: 14666657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems.
    Sharma S; Sharma SC
    Indian J Exp Biol; 1997 Oct; 35(10):1025-31. PubMed ID: 9475035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.